These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 583156)

  • 1. The production of thyroid-stimulating immunoglobulin (TSI) by lymphocytes from patients with Graves' disease cultured with human thyroid subcellular fractions.
    Sugenoya A; Trokoudes K; Row VV; Volpé R
    J Endocrinol Invest; 1978 Jul; 1(3):245-51. PubMed ID: 583156
    [No Abstract]   [Full Text] [Related]  

  • 2. Thyroid antigen stimulates lymphocytes from patients with Graves' disease to produce thyroid-stimulating immunoglobulin (TSI).
    Knox AJ; von Westarp C; Row VV; Volpé R
    J Clin Endocrinol Metab; 1976 Aug; 43(2):330-7. PubMed ID: 181397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid stimulating immunoglobulins: measurement and clinical use.
    Ollis CA; Tomlinson S; Munro DS
    Clin Sci (Lond); 1985 Aug; 69(2):113-21. PubMed ID: 2866060
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of thyroid antigens by the experimental production of precipitating antibodies to human thyroid fractions and the identification of an antibody which competes with long-acting thyroid stimulator (LATS) for thyroid binding.
    von Westarp C; Knox AJ; Row VV; Volpé R
    Acta Endocrinol (Copenh); 1977 Apr; 84(4):759-67. PubMed ID: 576759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro lymphocyte proliferation in response to polyclonal activators and microbial antigens, and production of immunoglobulins stimulating thyroid adenylate cyclase in Graves' disease.
    Bech K; Andersen V; Madsen SN
    Acta Endocrinol (Copenh); 1982 Jun; 100(2):252-5. PubMed ID: 6896786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a human monoclonal antibody from a Graves' disease patient that identifies a novel thyroid membrane antigen.
    Baker JR; Saunders NB; Kaulfersch W; Burman KD
    J Immunol; 1988 Apr; 140(8):2593-9. PubMed ID: 2895790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of the production of human thyroid-stimulating immunoglobulins (HTSI) by Graves' lymphocytes cultured in vitro with phytohaemagglutinin (PHA).
    Knox AJ; von Westarp C; Row VV; Volpé R
    Metabolism; 1976 Nov; 25(11):1217-23. PubMed ID: 185485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of thyroid adenyl cyclase by antisera to thyroid plasma membrane preparations: effects of IgG and non-IgG antiserum components.
    Ong M; Malkin DG; Malkin A
    Metabolism; 1986 Apr; 35(4):292-6. PubMed ID: 3754301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of thyroid stimulating immunoglobulins (TSI) and their Fab and Fc fragments on the activation of adenyl cyclase in thyroid gland cell membranes].
    Adler G; Nauman J; Wasilewska A
    Endokrynol Pol; 1980; 31(4):333-40. PubMed ID: 6893582
    [No Abstract]   [Full Text] [Related]  

  • 10. Changes in thyroid-stimulating immunoglobulins during antithyroid therapy.
    Fenzi G; Hashizume K; Roudebush CP; DeGroot LJ
    J Clin Endocrinol Metab; 1979 Apr; 48(4):572-6. PubMed ID: 581875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graves' IgG stimulation of continuously cultured rat thyroid cells: a sensitive and potentially useful clinical assay.
    Vitti P; Valente WA; Ambesi-Impiombato FS; Fenzi GF; Pinchera A; Kohn LD
    J Endocrinol Invest; 1982; 5(3):179-82. PubMed ID: 6286749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of cellular immune responses to thyrocyte membrane antigens and specific immunoregulatory defects in autoimmune thyroid disease.
    O'Brien CJ; Macchia E; Cundy TF; Concetti R; McSorley CG; MacFarlane IG; Vento S; Eddleston AL
    J Clin Lab Immunol; 1990 Jul; 32(3):103-8. PubMed ID: 1966945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoelectric focusing of thyroid-stimulating antibody of Graves' disease.
    Zakarija M; McKenzie JM
    Endocrinology; 1978 Oct; 103(4):1469-75. PubMed ID: 33803
    [No Abstract]   [Full Text] [Related]  

  • 14. Neutralization of the long-acting thyroid stimulator by thyroid subcellular fractions.
    Berumen FO; Lobsenz IL; Utiger RD
    J Lab Clin Med; 1967 Oct; 70(4):640-9. PubMed ID: 6072404
    [No Abstract]   [Full Text] [Related]  

  • 15. Thyroid-stimulating immunoglobulins in Graves' disease.
    Smith BR; Hall R
    Lancet; 1974 Aug; 2(7878):427-31. PubMed ID: 4137321
    [No Abstract]   [Full Text] [Related]  

  • 16. The pathogenesis of Graves' disease: an overview.
    Volpé R
    Clin Endocrinol Metab; 1978 Mar; 7(1):3-29. PubMed ID: 348355
    [No Abstract]   [Full Text] [Related]  

  • 17. Demonstration of the production of the long acting thyroid stimulator (LATS) by peripheral lymphocytes cultured in vitro.
    Wall JR; Good BF; Forbes IJ; Hetzel BS
    Clin Exp Immunol; 1973 Aug; 14(4):555-61. PubMed ID: 4201115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of parallel measurements of thyrotropin binding inhibiting immunoglobulins (TBII) and thyroid adenylate cyclase stimulating antibodies (TSAb) in Graves' disease after longterm antithyroid treatment.
    Bliddal H; Bech K; Siersbaek-Nielsen K; Friis T
    J Endocrinol Invest; 1983 Aug; 6(4):259-62. PubMed ID: 6139399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid stimulating immunoglobulin in Graves' disease.
    Luttrell BM; Hales IB
    Aust N Z J Med; 1981 Jun; 11(3):293-8. PubMed ID: 6170289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A reconsideration of a thyroid-stimulating immunoglobulin as the cause of hyperthyroidism in Graves' disease.
    McKenzie JM; Zakarija M
    J Clin Endocrinol Metab; 1976 Apr; 42(4):778-81. PubMed ID: 177449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.